Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD

Clinical trial NCT00574093 · COMPLETED

Trial details

NCT number: NCT00574093
Sponsor: Fondazione G.B. Bietti, IRCCS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neovascular Age Related Macular Degeneration

Start date: 2008-01-01
Primary completion: 2009-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.